Search

everythinglearnresearchcommunity

for

Search:↓

Hormones control reproduction and are crucial for body balance.

The guidelines advise against using testosterone and DHEA in women for most conditions due to safety and effectiveness concerns, but suggest considering testosterone for postmenopausal women with low sexual desire.

Hormones and metabolism play a complex role in prostate enlargement, and more research is needed to improve diagnosis and treatment.

Aromatase gene variation may increase female hair loss risk.

Impaired androgen production in 46,XY DSDs causes ambiguous genitalia and requires long-term care.

Effective hirsutism management requires identifying the cause, combining new and traditional treatments, and setting realistic expectations for patients.

The document concludes that treating androgen excess needs patience, managing expectations is important, and many drugs used are not officially approved, suggesting cosmetic options for mild cases.

Hormonal changes and psychological issues can cause sexual dysfunction in postmenopausal women. Behavioral therapy is recommended first, with hormone replacement helping some symptoms but not libido. Testosterone can improve libido, but its effects on overall sexual function are unclear. Emotional and relationship issues should be addressed before using medication, and the benefits and risks of testosterone supplementation should be considered.

Hyperandrogenism increases heart disease risk in premenopausal women, but this risk is linked to obesity in postmenopausal women.

While PCOS might increase the risk of heart disease, there's not strong evidence to prove it causes earlier heart problems.

Most patients with frontal fibrosing alopecia are postmenopausal women, and treatments like finasteride and dutasteride can improve or stabilize the condition.

Early diagnosis and individualized treatment improve outcomes for Congenital Adrenal Hyperplasia.

Some common medications can harm male fertility, but many effects can be reversed.

Hormonal treatment in transgender women reduces semen quality, but stopping treatment may improve it.

Using finasteride or dutasteride may cause long-lasting erectile dysfunction.

Hormone therapy for transgender females increases the risk of blood clots and requires careful dosing, monitoring, and lifelong management.

PCOS may start before birth, involves metabolic issues, and can be treated with drugs like metformin and lifestyle changes.

DHEA may help with sexual function when used intravaginally by menopausal women but is similar to hormone therapy in other aspects and might cause more side effects like acne and hair loss.

Women with polycystic ovary syndrome have a higher risk of certain fractures.

Genetic factors affect hair loss, and molecular testing may help predict, diagnose, and treat it.

Low birthweight and rapid weight gain after birth may increase the risk of developing polycystic ovary syndrome.

Finasteride can cause lasting sexual dysfunction, depression, and other side effects, needing more research for treatment.

The document concludes that breast pain should be managed with personalized treatment, starting with non-drug methods and progressing to medication if necessary, while considering side effects and patient needs.

Gender-affirming care for youth remained essential during the COVID-19 pandemic, with telemedicine playing a key role.

Finasteride and dutasteride are equally effective and safe for treating benign prostatic hyperplasia.

Testosterone and its metabolites have varied effects on different body systems, especially during puberty.

Some people experience lasting sexual, psychological, and sleep problems after using finasteride or SSRI antidepressants, possibly due to similar underlying causes.

Women with early-onset baldness should be checked for early bone loss, but bone density doesn't change with baldness severity.

High doses of testosterone disrupt hormone levels and receptor expression in the uterus, affecting fertility.